NORTHERN TRUST CORP - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 195 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,122,610
-16.9%
1,045,381
+3.5%
0.00%0.0%
Q2 2023$9,776,693
-9.5%
1,009,989
+2.5%
0.00%0.0%
Q1 2023$10,803,490
+143.5%
985,720
-4.0%
0.00%
+100.0%
Q4 2022$4,437,147
-41.3%
1,027,117
+2.2%
0.00%
-50.0%
Q3 2022$7,557,000
-26.2%
1,004,868
-1.4%
0.00%0.0%
Q2 2022$10,244,000
+709.8%
1,019,317
+897.3%
0.00%
Q1 2022$1,265,000
-45.5%
102,204
+0.7%
0.00%
Q4 2021$2,321,000
+8.3%
101,476
+4.8%
0.00%
Q3 2021$2,144,00096,8670.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 111,608$2,470,0003.15%
ACT CAPITAL MANAGEMENT, LLC 180,000$3,983,0002.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 167,889$3,715,0001.92%
DG Capital Management, LLC 402,200$8,901,0001.81%
NEA Management Company, LLC 5,172,683$114,471,0001.36%
KESTRA PRIVATE WEALTH SERVICES, LLC 801,100$17,728,0000.99%
Altium Capital Management LP 144,000$3,187,0000.84%
HighMark Wealth Management LLC 50,569$1,119,0000.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 123,500$2,724,0000.66%
SEVEN EIGHT CAPITAL, LP 288,840$6,392,0000.62%
View complete list of AURINIA PHARMACEUTICALS INC shareholders